vs

Side-by-side financial comparison of ICHOR HOLDINGS, LTD. (ICHR) and UNIVERSAL TECHNICAL INSTITUTE INC (UTI). Click either name above to swap in a different company.

ICHOR HOLDINGS, LTD. is the larger business by last-quarter revenue ($256.1M vs $221.4M, roughly 1.2× UNIVERSAL TECHNICAL INSTITUTE INC). UNIVERSAL TECHNICAL INSTITUTE INC runs the higher net margin — 0.2% vs -1.0%, a 1.2% gap on every dollar of revenue. On growth, UNIVERSAL TECHNICAL INSTITUTE INC posted the faster year-over-year revenue change (6.7% vs 4.7%). Over the past eight quarters, ICHOR HOLDINGS, LTD.'s revenue compounded faster (12.3% CAGR vs 11.7%).

Ichor Holdings Ltd. designs, manufactures and supplies critical fluid delivery systems, subsystems and related components for the global semiconductor manufacturing sector. Its products are integrated into front-end wafer processing equipment, supporting production of advanced logic, memory and specialty chips for leading semiconductor device and equipment makers across North America, East Asia and Europe.

Universal Technical Institute, Inc. (UTI) is a private for-profit system of technical colleges in the United States. It was established in 1965 by Robert Sweet.

ICHR vs UTI — Head-to-Head

Bigger by revenue
ICHR
ICHR
1.2× larger
ICHR
$256.1M
$221.4M
UTI
Growing faster (revenue YoY)
UTI
UTI
+2.0% gap
UTI
6.7%
4.7%
ICHR
Higher net margin
UTI
UTI
1.2% more per $
UTI
0.2%
-1.0%
ICHR
Faster 2-yr revenue CAGR
ICHR
ICHR
Annualised
ICHR
12.3%
11.7%
UTI

Income Statement — Q1 FY2026 vs Q2 FY2026

Metric
ICHR
ICHR
UTI
UTI
Revenue
$256.1M
$221.4M
Net Profit
$-2.5M
$433.0K
Gross Margin
12.6%
Operating Margin
88.2%
0.2%
Net Margin
-1.0%
0.2%
Revenue YoY
4.7%
6.7%
Net Profit YoY
45.8%
-60.5%
EPS (diluted)
$-0.07
$0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ICHR
ICHR
UTI
UTI
Q1 26
$256.1M
$221.4M
Q4 25
$223.6M
$220.8M
Q3 25
$239.3M
$222.4M
Q2 25
$240.3M
$204.3M
Q1 25
$244.5M
$207.4M
Q4 24
$233.3M
$201.4M
Q3 24
$211.1M
$196.4M
Q2 24
$203.2M
$177.5M
Net Profit
ICHR
ICHR
UTI
UTI
Q1 26
$-2.5M
$433.0K
Q4 25
$-16.0M
$12.8M
Q3 25
$-22.9M
$18.8M
Q2 25
$-9.4M
$10.7M
Q1 25
$-4.6M
$11.4M
Q4 24
$-3.9M
$22.2M
Q3 24
$-2.8M
$18.8M
Q2 24
$-5.1M
$5.0M
Gross Margin
ICHR
ICHR
UTI
UTI
Q1 26
12.6%
Q4 25
9.4%
Q3 25
4.6%
Q2 25
11.3%
Q1 25
11.7%
Q4 24
11.6%
Q3 24
13.2%
Q2 24
12.6%
Operating Margin
ICHR
ICHR
UTI
UTI
Q1 26
88.2%
0.2%
Q4 25
-6.2%
7.1%
Q3 25
-8.1%
11.2%
Q2 25
-2.0%
6.9%
Q1 25
-0.5%
8.1%
Q4 24
-0.5%
13.6%
Q3 24
-0.2%
13.3%
Q2 24
-1.1%
4.2%
Net Margin
ICHR
ICHR
UTI
UTI
Q1 26
-1.0%
0.2%
Q4 25
-7.1%
5.8%
Q3 25
-9.6%
8.4%
Q2 25
-3.9%
5.2%
Q1 25
-1.9%
5.5%
Q4 24
-1.7%
11.0%
Q3 24
-1.3%
9.6%
Q2 24
-2.5%
2.8%
EPS (diluted)
ICHR
ICHR
UTI
UTI
Q1 26
$-0.07
$0.01
Q4 25
$-0.46
$0.23
Q3 25
$-0.67
$0.33
Q2 25
$-0.28
$0.19
Q1 25
$-0.13
$0.21
Q4 24
$-0.11
$0.40
Q3 24
$-0.08
$0.35
Q2 24
$-0.15
$0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ICHR
ICHR
UTI
UTI
Cash + ST InvestmentsLiquidity on hand
$89.1M
$162.0M
Total DebtLower is stronger
$6.3M
$127.8M
Stockholders' EquityBook value
$668.0M
$339.9M
Total Assets
$972.5M
$852.2M
Debt / EquityLower = less leverage
0.01×
0.38×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ICHR
ICHR
UTI
UTI
Q1 26
$89.1M
$162.0M
Q4 25
$98.3M
$162.8M
Q3 25
$92.5M
$169.1M
Q2 25
$92.2M
$70.7M
Q1 25
$109.3M
$96.0M
Q4 24
$108.7M
$172.0M
Q3 24
$116.4M
$161.9M
Q2 24
$114.3M
$115.5M
Total Debt
ICHR
ICHR
UTI
UTI
Q1 26
$6.3M
$127.8M
Q4 25
$123.5M
$101.4M
Q3 25
$123.5M
$87.1M
Q2 25
$125.0M
$73.8M
Q1 25
$126.8M
$94.4M
Q4 24
$128.5M
$120.1M
Q3 24
$130.3M
$125.7M
Q2 24
$130.2M
$137.3M
Stockholders' Equity
ICHR
ICHR
UTI
UTI
Q1 26
$668.0M
$339.9M
Q4 25
$663.9M
$335.9M
Q3 25
$676.2M
$328.1M
Q2 25
$694.1M
$306.8M
Q1 25
$700.4M
$293.9M
Q4 24
$698.3M
$280.0M
Q3 24
$697.3M
$260.2M
Q2 24
$694.9M
$239.4M
Total Assets
ICHR
ICHR
UTI
UTI
Q1 26
$972.5M
$852.2M
Q4 25
$942.9M
$834.0M
Q3 25
$966.6M
$826.1M
Q2 25
$985.1M
$740.8M
Q1 25
$1.0B
$720.4M
Q4 24
$995.6M
$753.8M
Q3 24
$975.9M
$744.6M
Q2 24
$947.7M
$706.0M
Debt / Equity
ICHR
ICHR
UTI
UTI
Q1 26
0.01×
0.38×
Q4 25
0.19×
0.30×
Q3 25
0.18×
0.27×
Q2 25
0.18×
0.24×
Q1 25
0.18×
0.32×
Q4 24
0.18×
0.43×
Q3 24
0.19×
0.48×
Q2 24
0.19×
0.57×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ICHR
ICHR
UTI
UTI
Operating Cash FlowLast quarter
$7.1M
Free Cash FlowOCF − Capex
$-10.0M
FCF MarginFCF / Revenue
-3.9%
Capex IntensityCapex / Revenue
2.8%
Cash ConversionOCF / Net Profit
16.33×
TTM Free Cash FlowTrailing 4 quarters
$-16.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ICHR
ICHR
UTI
UTI
Q1 26
$7.1M
Q4 25
$9.2M
$3.1M
Q3 25
$9.2M
$57.1M
Q2 25
$-7.5M
$18.1M
Q1 25
$19.0M
$-789.0K
Q4 24
$-2.5M
$23.0M
Q3 24
$8.1M
$67.5M
Q2 24
$17.5M
$10.0M
Free Cash Flow
ICHR
ICHR
UTI
UTI
Q1 26
$-10.0M
Q4 25
$5.9M
$-19.2M
Q3 25
$2.1M
$40.6M
Q2 25
$-14.8M
$6.8M
Q1 25
$496.0K
$-11.7M
Q4 24
$-6.9M
$19.6M
Q3 24
$2.2M
$60.0M
Q2 24
$14.6M
$3.0M
FCF Margin
ICHR
ICHR
UTI
UTI
Q1 26
-3.9%
Q4 25
2.6%
-8.7%
Q3 25
0.9%
18.3%
Q2 25
-6.2%
3.4%
Q1 25
0.2%
-5.7%
Q4 24
-3.0%
9.7%
Q3 24
1.0%
30.6%
Q2 24
7.2%
1.7%
Capex Intensity
ICHR
ICHR
UTI
UTI
Q1 26
2.8%
Q4 25
1.5%
10.1%
Q3 25
3.0%
7.4%
Q2 25
3.0%
5.5%
Q1 25
7.6%
5.3%
Q4 24
1.9%
1.7%
Q3 24
2.8%
3.8%
Q2 24
1.4%
4.0%
Cash Conversion
ICHR
ICHR
UTI
UTI
Q1 26
16.33×
Q4 25
0.24×
Q3 25
3.04×
Q2 25
1.69×
Q1 25
-0.07×
Q4 24
1.04×
Q3 24
3.58×
Q2 24
2.01×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons